Extracorporeal albumin dialysis: A procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis

American Journal of Gastroenterology

Volumn 99, Issue 6, 2004, Pages 1105-1110

  Parés, Albert ^a   Cisneros, Laura ^b   Salmerón, Joan M ^b   Caballería, Llorenç ^b   Mas, Antoni ^b   Torras, Albert ^b   Rodés, Juan ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; RETINOL; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILE ACID BLOOD LEVEL; BILE SECRETION; CASE REPORT; CHOLESTASIS; EXTRACORPOREAL ALBUMIN DIALYSIS; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; INTRACTABLE PRURITUS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PRURITUS; RENAL DIALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 3142729446     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.30204.x     Document Type: Article

References (34)

1. Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973;289:674-8.
2. Parés A, Bruguera M, Rodés J. Cirrosis biliar primitiva. Evolución clínica y criterios de valor pronóstico. Gastroenterol Hepatol 1981;4:76-81
3. Poupon RE, Balkau B, Eschwege E, et al. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC study group. N Engl J Med 1991;324:1548-54.
4. Parés A, Caballeria L, Rodés J, et al. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis. Results of a double blind randomized trial. J Hepatol 2000;32:561-6.
5. Benhamou JP. Indications for liver transplantation in primary biliary cirrhosis. Hepatology 1994;20:11S-13S.
6. Neuberger J. Transplantation for primary biliary cirrhosis. Semin Liver Dis 1997;17:137-46.
7. Bergasa NV, Jones EA. The pruritus of cholestasis. Semin Liver Dis 1993;13:319-27.
8. Rodés J, Parés A. Treatment of pruritus of chronic cholestasis. In Gentilini P, et al., eds. Cholestasis. Amsterdam: Elsevier Science BV, 1994:267-71.
9. Bachs L, Pares A, Elena M, et al. Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet 1989;1:574-6.
10. Bachs L, Parés A, Elena M, et al. Effects of long-term rifampicin administration in primary biliary cirrhosis. Gastroenterology 1992;102:2077-80.
11. Borgeat A, Wilder-Smith OHG, Mentha G. Subhypnotic doses of propofol relieve pruritus associated with liver disease. Gastroenterology 1993;104:244-7.
12. Gonzalez M, Iglesias J, Tiribelli C, et al. Epomediol ameliorates pruritus in patients with intrahepatic cholestasis of pregnancy. J Hepatol 1992;16:241-2.
13. Frezza M, Surrenti C, Manzillo G, et al. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology 1990;99:211-5.
14. Watson W. Intravenous lignocaine for relief of intractable itch. Lancet 1973;1:211.
15. Lloyd-Thomas HGL, Sherlock S. Testosterone therapy for the pruritus of obstructive jaundice. Br Med J 1952;2:1289-91.
16. Muller C, Pongratz S, Pidlich J, et al. Treatment of pruritus of chronic liver disease with the 5-hydroxy-tryptamine receptor type 3 antagonist ondansetron: A randomized, placebo-controlled, double-blind cross-over trial. Eur J Gastroenterol Hepatol 1998;10:865-70.
17. Bergasa NV, Alling DW, Talbot TL, et al. Naloxone ameliorates the pruritus of cholestasis: Results of a double-blind randomized placebo-controlled trial. Ann Intern Med 1995;123:161-167.
18. Bergasa NV, Schmitt JP, Talbot TL, et al. Open label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology 1998;27:679-84.
19. Wolfhagen FH, Sternieri E, Hop WC, et al. Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study. Gastroenterology 1997;113:1264-9.
20. Hanid MA, Levi AJ. Phototherapy for pruritus in primary biliary cirrhosis. Lancet 1980;2:530.
21. Alarabi AA, Wikström B, Loof L, et al. Treatment of pruritus in cholestatic jaundice by bilirubin and bile acid adsorbing resin column plasma perfusion. Scand J Gastroenterol 1992;27:223-6.
22. Cohen LB, Ambinder EP, Wolke AM, et al. Role of plasmapheresis in primary biliary cirrhosis. Gut 1985;26:291-4.
23. Quintero E, Puig L, Parés A, et al. Utilidad del recambio plasmáitco intermitente en la cirrosis biliar primaria. Gastroenterol Hepatol 1986;9:329-33.
24. Whitington P, Whitington G. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 1988;95:130-6.
25. Hollands CM, Rivera-Pedrogo FJ, Gonzalez-Vallina R, et al. Ileal exclusion for Byler's disease: An alternative surgical approach with promising early results for pruritus. J Paediatr Surg 1998;33:220-4.
26. Mitzner S, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000;6:277-86.
27. Talbot TL, Schmitt JM, Bergasa NV, et al. Application of piezofilm technology for the quantitative assessment of pruritus. Biomed Instrum Technol 1991;25:400-3.
28. Stange J, Hassanein TI, Mehta R, et al. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: A summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002;26:103-10
29. Zakaria N, Wendon J, Creamer D, et al. Albumin dialysis (MARS device) relieves cholestatic pruritus in a dramatic but non-sustained manner. Gut 2002;50:A118 (abstract).
30. Freedman MR, Holzbach RT, Ferguson DR. Pruritus in cholestasis: No direct causative role for bile acid retention. Am J Med 1981;70:1011-6.
31. Ricci P, Hofmann AF, Hagey LR, et al. Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis. Dig Dis Sci 1998;43:1292-5.
32. Lauterburg BH, Pineda AA, Dickson ER, et al. Plasmaperfusion for the treatment of intractable pruritus of cholestasis. Mayo Clinic Proc 1978;53:403-7.
33. Jones EA, Bergasa NV. The pruritus of cholestasis: From bile acid to opiate agonists. Hepatology 1990;11:884-7.
34. Bergasa N, Thomas D, Vergalla J, et al. Serum extracts from cholestatic patients induce naloxone-reversible centrally-mediated facial scratching in monkeys. Life Sci 1992;53:1253-8.